A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants
Clinical trial NCT06504043 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06504043
- Sponsor
- Hasten Biopharmaceutical Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2025-01-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.